When asked about the macro environment, lead with the Fed's on-hold posture and its direct impact on deal activity — "With rates holding at 4.25–4.50% and the market pricing limited cuts, we're in a higher-for-longer regime that compresses LBO returns and forces sponsors to be more selective on entry multiples." Connect the 10-year yield to valuation multiples: sustained elevated rates mean continued DCF compression for long-duration growth assets, which is why strategic M&A by cash-rich corporates is outpacing financial sponsor activity right now. Tariffs add a second layer — cross-border deal structuring has become more complex as buyers underwrite trade policy risk into deal economics.

Credit market conditions are directly relevant to your LBO and leveraged finance answers. HY spreads at 400bps means the all-in cost of high yield debt has risen meaningfully — frame this as a constraint on sponsor deal economics and a reason why financial buyers are demanding lower entry multiples to clear their return hurdles. The bifurcation between IG-quality credits (still well-bid) and HY/leveraged credits (wider, more selective) is the key dynamic to articulate. If asked about LBO financing, note that markets are open for quality assets but lenders are stress-testing for tariff exposure and AI disruption risk in ways they weren't 18 months ago.

M&A activity questions are your opportunity to demonstrate genuine market awareness. Lead with the "conviction not volume" characterization of the current cycle — boards are acting decisively on transformative deals rather than pursuing tuck-in acquisitions. The AI super-sector narrative is essential: companies are acquiring capabilities they cannot build organically fast enough, and the power infrastructure constraint is creating a second-order M&A wave in energy and utilities. For healthcare questions, connect the biotech acquisition wave to the patent cliff math: large pharma loses $200B+ in revenues by 2030, making acquisitions economically necessary at almost any price for differentiated science.

Sector knowledge signals genuine market engagement to interviewers. Pick one or two sectors most relevant to the group you are interviewing with and go deeper. For tech groups, the AI infrastructure buildout and the power constraint is your anchor — "The limiting factor for AI capex is no longer chips, it's megawatts — which is why we're seeing M&A in utilities and energy infrastructure that would have seemed unrelated to tech two years ago." For healthcare, connect the biotech acquisition wave to the patent cliff math. For consumer, the Pernod/Brown-Forman situation is a live case study in strategic logic — what synergies justify the premium?

ECM market conditions are a window into overall risk appetite. The selective IPO window in Q2 2026 reflects the classic dynamic — companies IPO when they can, not when they must — and the current macro backdrop is not providing the stable equity conditions sponsors need to maximize IPO proceeds. Frame the convert market as a sign of financial creativity: when equity is expensive and debt is tight, converts allow issuers to split the difference. For ECM interview questions, connect VIX levels to IPO execution risk — elevated volatility means wider price talk, higher discounts, and more selective institutional demand.

Restructuring knowledge differentiates candidates who understand the full deal lifecycle. Lead with the maturity wall concept — $215B in loans maturing creates refinancing stress for companies that cannot grow into their leverage multiples. The software sector situation is a live case study: AI disruption concerns have repriced credit risk for leveraged software issuers dramatically, creating a barbell — companies that can demonstrate AI resilience refinance fine, those that cannot face distressed dynamics despite having serviceable debt levels 18 months ago. The office CRE situation remains the textbook distressed scenario: rising vacancies plus floating rate debt plus falling valuations equals forced restructuring.

IPO pipeline questions test your ability to connect market conditions to new issuance decisions. The key framework: companies IPO when they can, not when they must — the current tariff-driven volatility means sponsors are rationally waiting for a cleaner window rather than leaving valuation on the table. Klarna is the most useful live case study — delayed from a 2022 peak valuation of $46B, now targeting $15–20B, illustrating how companies wait for valuation recovery before proceeding. The record IG issuance wave is the counterpoint — investment grade corporates are rushing to market ahead of anticipated Fed cuts, front-running the rate decline to lock in current spreads.

PE and sponsor activity is directly relevant for any leveraged finance or M&A interview. Frame the current environment as a financing story: higher rates and wider spreads have compressed LBO deal economics, forcing sponsors to demand lower entry multiples to clear 20%+ IRR hurdles. The exit backlog is the defining PE dynamic of 2025–2026 — GPs hold $3.2T in unrealized portfolio value globally and the pressure to return capital to LPs is creating a multi-year exit supercycle when conditions improve. Continuation vehicles are the bridge solution — understand the mechanics and the LP alignment questions they raise.